Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Nat Genet. 2013 Dec;45(12):1494-8. doi: 10.1038/ng.2803. Epub 2013 Oct 20.
Recent genomic profiling of childhood acute lymphoblastic leukemia (ALL) identified a high-risk subtype with an expression signature resembling that of Philadelphia chromosome-positive ALL and poor prognosis (Ph-like ALL). However, the role of inherited genetic variation in Ph-like ALL pathogenesis remains unknown. In a genome-wide association study (GWAS) of 511 ALL cases and 6,661 non-ALL controls, we identified a susceptibility locus for Ph-like ALL (GATA3, rs3824662; P = 2.17 × 10(-14), odds ratio (OR) = 3.85 for Ph-like ALL versus non-ALL; P = 1.05 × 10(-8), OR = 3.25 for Ph-like ALL versus non-Ph-like ALL), with independent validation. The rs3824662 risk allele was associated with somatic lesions underlying Ph-like ALL (CRLF2 rearrangement, JAK gene mutation and IKZF1 deletion) and with variation in GATA3 expression. Finally, genotype at the GATA3 SNP was also associated with early treatment response and risk of ALL relapse. Our results provide insights into interactions between inherited and somatic variants and their role in ALL pathogenesis and prognosis.
最近对儿童急性淋巴细胞白血病(ALL)的基因组分析确定了一种高风险亚型,其表达特征类似于费城染色体阳性 ALL 和预后不良(Ph-like ALL)。然而,遗传变异在 Ph-like ALL 发病机制中的作用尚不清楚。在对 511 例 ALL 病例和 6661 例非 ALL 对照进行的全基因组关联研究(GWAS)中,我们确定了 Ph-like ALL 的易感基因座(GATA3,rs3824662;P=2.17×10(-14),OR=3.85 用于 Ph-like ALL 与非 ALL;P=1.05×10(-8),OR=3.25 用于 Ph-like ALL 与非 Ph-like ALL),并进行了独立验证。rs3824662 风险等位基因与 Ph-like ALL 的体细胞病变(CRLF2 重排、JAK 基因突变和 IKZF1 缺失)以及 GATA3 表达的变化有关。最后,GATA3 SNP 的基因型也与早期治疗反应和 ALL 复发的风险有关。我们的研究结果为遗传和体细胞变异之间的相互作用及其在 ALL 发病机制和预后中的作用提供了新的认识。